2007
DOI: 10.1021/bi701255m
|View full text |Cite
|
Sign up to set email alerts
|

Phage Display and Peptide Mapping of an Immunoglobulin Light Chain Fibril-Related Conformational Epitope

Abstract: Amyloid fibrils and partially unfolded intermediates can be distinguished serologically from native amyloidogenic precursor proteins or peptides. In this regard, we previously had reported that mAb 11-1F4, generated by immunizing mice with a thermally denatured variable domain (V L ) fragment of the human κ4 Bence Jones protein Len, bound to a non-native conformational epitope located within the N-terminal 18 residues of fibrillar, as well as partially denatured, Ig light chains (O'Nuallain B. et al. (2006) Bi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 52 publications
0
20
0
Order By: Relevance
“…Although proteolysis of the precursor protein is common in amyloid fibrils (Bohne et al, 2004; Monti et al, 2005; Röcken et al, 2006; Enqvist et al, 2009), this is the first example of fibril-specific mAbs that target a neo-epitope formed as a result of proteolytic cleavage. In contrast, other reported anti-fibril-mAbs bind conformational epitopes present on the non-native, fibrillar form of the amyloid precursor protein, but not the native, soluble, circulating molecule (O’Nuallain et al, 2005, 2007). …”
Section: Discussionmentioning
confidence: 92%
“…Although proteolysis of the precursor protein is common in amyloid fibrils (Bohne et al, 2004; Monti et al, 2005; Röcken et al, 2006; Enqvist et al, 2009), this is the first example of fibril-specific mAbs that target a neo-epitope formed as a result of proteolytic cleavage. In contrast, other reported anti-fibril-mAbs bind conformational epitopes present on the non-native, fibrillar form of the amyloid precursor protein, but not the native, soluble, circulating molecule (O’Nuallain et al, 2005, 2007). …”
Section: Discussionmentioning
confidence: 92%
“…10,11 Thus, the inability of the radiolabeled antibody to bind certain AL deposits, both in vivo and in vitro, may reflect a Consecutive tissue sections from each patient (AL 2, lymph node; AL 11, bone marrow, and AL 12, liver) were subjected to histochemical (HC) staining with Congo red (CR, top) or immunohistochemical (IHC) studies using, as primary reagent, mAb 11-1F4 (middle), or, as a negative control, the antibody preincubated with a 22-mer peptide containing the conformational fibril-related epitope recognized by mAb 11-1F4 (bottom). Photomicrographs were acquired with a Leica DM 500 light microscope equipped with cross-polarizing filters.…”
Section: Resultsmentioning
confidence: 99%
“…10,11 Furthermore, when administered to mice bearing subcutaneous human AL amyloidomas, the antibody bound to the pathologic material and initiated an inflammatory response that led to elimination of the induced tumors. 12 Notably, we also demonstrated that m11-1F4, after radiolabeling with the positron-emitting isotope I-124, imaged the xenograft, as evidenced by micropositron emission tomography/computed tomography (PET/CT).…”
Section: Introductionmentioning
confidence: 99%
“…To prove this point, we decided to perform alanine-scanning mutagenesis. It is commonly used to identify specific amino acid residues responsible for peptide function, stability, and conformation (36). Synthetic peptides were made whereby each residue of G2 was sequentially replaced with an Ala residue, and corresponding changes in G2 peptide were evaluated for the ability to affect viral entry (Fig.…”
Section: Identification Of Hs and 3-os Hs-binding Peptides Thatmentioning
confidence: 99%